Literature DB >> 14715359

Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure.

Uri Elkayam1, Mohammed W Akhter, Harpreet Singh, Salman Khan, Ahsan Usman.   

Abstract

The results of this study showed an advantage of nesiritide compared with high-dose nitroglycerin in the treatment of patients with decompensated heart failure. Nesiritide resulted in an early decrease in pulmonary capillary wedge pressure (< or =15 minutes), which was sustained throughout the study period (24 hours) without the need for up-titration. In contrast, the onset of the nitroglycerin-mediated hemodynamic effect was delayed, and despite aggressive up-titration, the decrease in pulmonary capillary wedge pressure was gradually attenuated because of the early development of tolerance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715359     DOI: 10.1016/j.amjcard.2003.09.051

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  20 in total

Review 1.  Ultrafiltration in decompensated heart failure.

Authors:  Brian E Jaski; David Miller
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 2.  Nesiritide in acute decompensated heart failure: current status and future perspectives.

Authors:  Selma F Mohammed; Josef Korinek; Horng H Chen; John C Burnett; Margaret M Redfield
Journal:  Rev Cardiovasc Med       Date:  2008       Impact factor: 2.930

3.  Acute Heart Failure Treatment.

Authors:  Phillip D Levy; Abdel Bellou
Journal:  Curr Emerg Hosp Med Rep       Date:  2013-06-01

4.  Effect of rhBNP on renal function in STEMI-HF patients with mild renal insufficiency undergoing primary PCI.

Authors:  Kun Xing; Xianghua Fu; Yanbo Wang; Wei Li; Xinshun Gu; Guozhen Hao; Qing Miao; Shiqiang Li; Yunfa Jiang; Weize Fan; Wei Geng
Journal:  Heart Vessels       Date:  2015-01-31       Impact factor: 2.037

Review 5.  Decongestion in acute heart failure.

Authors:  Robert J Mentz; Keld Kjeldsen; Gian Paolo Rossi; Adriaan A Voors; John G F Cleland; Stefan D Anker; Mihai Gheorghiade; Mona Fiuzat; Patrick Rossignol; Faiez Zannad; Bertram Pitt; Christopher O'Connor; G Michael Felker
Journal:  Eur J Heart Fail       Date:  2014-03-05       Impact factor: 15.534

6.  Pulmonary Oedema-Therapeutic Targets.

Authors:  Ovidiu Chioncel; Sean P Collins; Andrew P Ambrosy; Mihai Gheorghiade; Gerasimos Filippatos
Journal:  Card Fail Rev       Date:  2015-04

Review 7.  Strategies to reduce length of stay and costs associated with decompensated heart failure.

Authors:  J Thomas Heywood; Mitchell T Saltzberg
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 8.  What's new in the treatment of acute heart failure?

Authors:  Van N Selby; John R Teerlink
Journal:  Curr Cardiol Rep       Date:  2013-09       Impact factor: 2.931

Review 9.  Current treatment options for early management in acute decompensated heart failure.

Authors:  Jonathan G Howlett
Journal:  Can J Cardiol       Date:  2008-07       Impact factor: 5.223

Review 10.  Lack of evidence for intravenous vasodilators in ED patients with acute heart failure: a systematic review.

Authors:  Pauline Alexander; Lora Alkhawam; Jason Curry; Phillip Levy; Peter S Pang; Alan B Storrow; Sean P Collins
Journal:  Am J Emerg Med       Date:  2014-09-18       Impact factor: 2.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.